Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=nvaxLatest Financial News for Novavax, Inc.en-usFri, 18 Dec 2009 21:02:05 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/mfool/rss/SIG=13blal5po/*http%3A//www.fool.com/investing/international/2009/12/18/swine-flu-just-isnt-bringing-home-the-bacon.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2810478386Fri, 18 Dec 2009 21:02:05 Etc/GMThttp://us.rd.yahoo.com/finance/external/investopedia/rss/SIG=127dcn45s/*http%3A//stocks.investopedia.com/stock-analysis/cotd/SVA20091214.aspx?partner=YahooSAyahoo_finance/1328726019Wed, 16 Dec 2009 19:52:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=132c2camq/*http%3A//www.fool.com/investing/high-growth/2009/12/14/this-just-in-upgrades-and-downgrades.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/595656279Mon, 14 Dec 2009 20:03:15 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091209/us_novavax_stock_offering.html?.v=4Biotech drug developer Novavax Inc. said Wednesday it closed a public offering for 6.8 million shares of common stock. The company announced the offering, at $3.30 per share, Nov. 20.yahoo_finance/1204428557Wed, 9 Dec 2009 16:39:03 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=11kitjnkn/*http%3A//www.marketwatch.com/News/Story/Story.aspx?guid=%7b3BDC97CC-48B2-43F3-9FCA-5307324EB051%7d&siteid=yhoof2yahoo_finance/3821347133Wed, 9 Dec 2009 14:09:47 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091209/ph23482.html?.v=1Novavax, Inc. today announced that on November 25, 2009, it closed its previously announced public offering of 6,800,000 shares of its common stock at $3.30 per share.yahoo_finance/2548244879Wed, 9 Dec 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12lkad81f/*http%3A//www.fool.com/investing/high-growth/2009/12/06/better-buy-celg-or-genz.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2968717837Sun, 6 Dec 2009 05:11:57 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12s3qvcr5/*http%3A//www.thestreet.com/_yahoo/story/10637652/1/seachange-tenet-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2980161883Thu, 3 Dec 2009 13:37:40 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=NVAXyahoo_finance/4264121134Thu, 3 Dec 2009 12:14:33 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12oeia7dh/*http%3A//seekingalpha.com/article/176241-equities-update-flat-finish-as-energies-weigh?source=yahooyahoo_finance/1319120414Wed, 2 Dec 2009 21:31:53 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12og2mge7/*http%3A//www.marketwatch.com/news/story/dyax-santarus-cytrx-soar-hemispherx/story.aspx?guid=%7BF00AAFBE%2D8CA9%2D4683%2DA193%2D024E82B43CA3%7D&siteid=yhoofDyax's shares gain on news the biotech company has won regulatory approval for its drug to treat the rare disorder hereditary angioedema.yahoo_finance/139779039Wed, 2 Dec 2009 16:38:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12ouo2nkf/*http%3A//www.marketwatch.com/news/story/dyax-rockets-hemispherx-craters-fda/story.aspx?guid=%7BF00AAFBE%2D8CA9%2D4683%2DA193%2D024E82B43CA3%7D&siteid=yhoofyahoo_finance/2733770889Wed, 2 Dec 2009 15:26:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091202/nvax8-k.htmlyahoo_finance/4143033833Wed, 2 Dec 2009 15:14:30 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh22851_2009-12-02_14-24-07_bng415500_newsml&rpc=44&type=marketsNewsyahoo_finance/1679995368Wed, 2 Dec 2009 14:24:07 Etc/GMThttp://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=13o7lc159/*http%3A//www.foxbusiness.com/story/markets/industries/health-care/novavax-shares-boost-favorable-vaccine-test-results/yahoo_finance/180145629Wed, 2 Dec 2009 14:09:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12qd6lq92/*http%3A//www.thestreet.com/_yahoo/story/10636569/1/dyax-rf-micro-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3201808439Wed, 2 Dec 2009 13:40:03 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091202/us_novavax_study.html?.v=1Novavax Inc. said Wednesday that the swine flu vaccine it's developing prompted an immune system response in patients during a midstage study being conducted in Mexico.yahoo_finance/1148250067Wed, 2 Dec 2009 13:27:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091202/ph19684.html?.v=1Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle pandemic influenza vaccine.yahoo_finance/1888151825Wed, 2 Dec 2009 13:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091201/nvax8-k.htmlyahoo_finance/99242052Tue, 1 Dec 2009 22:01:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12v86gcjg/*http%3A//www.thestreet.com/_yahoo/story/10635371/1/anthracite-netlist-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/949977124Tue, 1 Dec 2009 13:37:38 Etc/GMT